To: LLCF who wrote (653 ) 8/12/1999 2:46:00 AM From: Mike McFarland Read Replies (1) | Respond to of 4474
The apoptosis article at Biospace lists these companies specializing... Apoptogen, Apoptosis Terapies Inc., ATI/Immunogen/ Biochem Pharma, Cell Pathways, Cyclacel, Cytovia, Idun, Prolifix. Other biotech companies with significant programs include...MLNM, VRTX, CHIR, Ilex Oncology, ALXN, GNE--DNA I guess now, Mitotix, Techniclone, OxiGene, and IMNX. A query on recap gives a few more, including LXR Biotechnology, Genta, Tularik, and of course Ariad's ARGENT-AP1903 GvH trial. There are a few more companies listed on recap, but apoptosis might not be a specific enough query, lots of extra trials tend to bleed through on recap. The biospace article is just the thing for newbies, wish I'd had it to read a year ago. I might not have been so impressed with Ariad's efforts if I'd known the lists of companies in here were so long, or that the apoptosis pathway was so convoluted, TRAIL, Caspases, TNF. Makes Fas look positively boring. Here is the url to the biospace article...biospace.com Looks like there could be a pretty good shake out in ARIA now that the stock is poised to go below a buck. If I wasn't so stubborn I'd probably sell my shares and go trade internuts. Clearly this is not going to be a fun time to be watching the quotes for me. I wanted to post this last message before I go offline--I just cant bear to watch my account get pummeled any further. I'll be back in a few weeks (unless I cant force myself to keep the PC off--it is terribly addictive, and mostly a waste of time). When I get back I'll buy a couple stocks for the Mr. Green Genes portfolio over on the son of T/FIF thread. See you all later, if Ariad really plunges I may get stopped out entirely. But if I don't come back to SI for awhile, no worries--it just means I've found a new hobby. Biotech stocks were fun, maybe it got the best of me though and it's time to get on with something new. Maybe I'll take up a sport.